Algeria vs Kazakhstan: Cause of death, by non-communicable diseases, ages 5-14, female
Algeria
44.3%
in 2021
Kazakhstan
43.7%
in 2021
Algeria rank
79th
Kazakhstan rank
80th
Cause of death, by non-communicable diseases, ages 5-14, female over time
- Algeria
- Kazakhstan
How they compare
Algeria currently reports 44.3% against 43.7% in Kazakhstan, a difference of 0.6%.
Across all 6 years both countries report, Algeria has been ahead every year.
Algeria ranks 79th and Kazakhstan ranks 80th of 184 countries.
Algeria has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Algeria | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 42.7% | 37.9% | 4.8% | Algeria |
| 2010s | 46.6% | 43.8% | 2.8% | Algeria |
| 2020s | 47.3% | 44.8% | 2.5% | Algeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, female, Algeria or Kazakhstan?
- Algeria, at 44.3% against 43.7% in Kazakhstan as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, female between Algeria and Kazakhstan?
- 0.6%, with Algeria ahead.
- How many years of comparable data are there for Algeria and Kazakhstan?
- 6 years are reported by both, from 2000 to 2021.
- How do Algeria and Kazakhstan rank globally for cause of death, by non-communicable diseases, ages 5-14, female?
- Algeria ranks 79th and Kazakhstan ranks 80th of 184 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.